Cancer clinical trials are research studies of humans designed to answer specific questions related to cancer. Meticulously conducted cancer clinical trials are the fastest method to establish safe and effective preventive, diagnostic, treatment, and supportive care interventions (National Cancer Institute [NCI], 2004) . Complementary and alternative medicine (CAM) is a pervasive component in cancer care, and cancer CAM clinical trials are increasing in number and expanding in design. Oncology nurses are at the forefront of clinical supportive care for patients enrolled in clinical trials. They also are involved in designing clinical trials, accruing participants, monitoring, managing and analyzing data, and reporting results.
The author of this article performed a search for conventional biomedical and CAM clinical trials in the United States and offers a synopsis of how to locate active trials and published results. Part II of this article, to be published in a future issue, will review significant aspects of cancer CAM clinical trials, such as accrual, ethical and methodologic considerations, use of CAM in symptom management trials, and the role of nursing in cancer CAM.
Types of Clinical Trials
Six predominant types of clinical trials exist: prevention, screening, diagnostic, treatment, supportive care, and genetic studies (NCI, 2004 
Phases of Clinical Trials
Three main phases of clinical trials exist: phase I, II, and III. Phase I trials generally involve a small number of patients (N < 50) and focus on how, when, and at which dose a new drug should be given. Phase II trials generally involve one type of cancer, focus on drug safety and efficacy, and comprise the majority of conventional biomedical and cancer CAM clinical trials. Phase III trials generally involve a larger number of patients (N > 100), use randomization, and compare new approaches with standard ones. Phase I and III trials are fewer in number for conventional biomedical and cancer CAM clinical trials. After a treatment has been approved by the U.S. Food and Drug Administration (FDA) and is marketed, it is studied in a larger, phase IV trial (N > 1,000) to evaluate side effects that were not apparent in the phase III trial. 
Locating Clinical Trials
Despite increased interest in CAM clinical trials in general, only 3%-5% of patients with cancer in the United States participate in any type of clinical trials (Varricchio, McCabe, Trimble, & Korn, 1996) . Typical sponsors of trials are NCI-generated programs such as the Cancer Centers Program, Clinical Trials Cooperative Group Program, Cancer Trials Support Unit, Community Clinical Oncology Program, and the National Institutes of Health (NIH) Clinical Center. Pharmaceutical and biotechnology companies sponsor trials that take place in academic centers, hospitals, clinics, and doctors' offices. A metasearch for eligible databases revealed four optimal sources for retrieving clinical trial information related to cancer care in the United States: Center Watch™ Clinical Trials Listing Service, ClinicalTrials.gov, PDQ, and Trial Check™. These databases provide varying levels of access for healthcare providers, patients, and researchers (see Table 2 ). This material is protected by U.S. copyright law. Unauthorized reproduction is prohibited. To purchase quantity reprints, please e-mail reprints@ons.org or to request permission to reproduce multiple copies, please e-mail pubpermissions@ons.org.
